Categories for Drug Litigation

More than 300,000 people have hip replacement surgery in the United States every single year, and for the vast majority of people it is a surgery that is monumentally beneficial to patients who finally obtain pain relief and can go about living a happier and healthier lifestyle. Ideally, hip replacement surgery should be expected to last 20 years or longer, but it is not a...

read more

A months-long trial in San Francisco has ended after a jury found that Monsanto’s Roundup weed killer contributed to a school groundskeeper’s lymphoma, awarding the man $289 million in damages in this landmark decision. Dewayne Johnson’s case was the first to go to trial because his doctors said he was near death due to his terminal cancer and California offers an expedited trial in those...

read more

What is Metallosis?

August 17, 2018

For most people, having hip replacement surgery comes as a great relief once they are back on their feet, and the majority of patients find a renewed mobility and no more pain or stiffness. However, a growing number of hip replacement patients have suffered serious complications that have resulted in a diminished quality of life and impacted their future. Hip replacement surgery has been on...

read more

Prescription drugs are usually subject to several rounds of testing and trials before they can be sold to consumers, but all too often we have seen dangerous drugs come to market that have harmful or even deadly side effects. Some prescription drugs even come to be used outside their original scope of approval in areas that they have not been tested for nor approved for...

read more

As consumers, we place a great deal of faith in doctors and drug manufacturers to provide us with products which are not only safe to use but also beneficial to us in some way. Sometimes, they are drugs that are meant to help us overcome an illness or disease, to manage the symptoms, or even to overcome minor problems on a day-to-day basis. One thing...

read more

Pradaxa was initially approved by the U.S. Food and Drug Administration (FDA) in the Fall of 2010 and was designed to prevent strokes associated with atrial fibrillation, or a fluttering heart rhythm. The drug is an anticoagulant that inhibits the production of thrombin, an enzyme necessary for the formation of blood clots. The Pradaxa blood thinner drug was subsequently approved for the treatment of deep...

read more

The popular herbicide, Roundup, was introduced by Monsanto in 1974 and over the course of nearly 35 years, it has grown into the world’s most popular weed killer. Roundup is widely used by farmers, homeowners and landscaping professionals, and has been widely adopted around the world. Unfortunately, over the past few years, studies have found that the active ingredient in Roundup known as glyphosate is...

read more

When attempting to identify the underlying causes of America’s nation-wide opioid epidemic, it is impossible not to mention the role of manufacturers and distributors in creating this monster. Yet, throughout the growing crisis, these multi-billion-dollar companies have been able to avoid any serious accountability, and not only that, but they’ve also received in record profits to the tune of many millions of dollars in the...

read more

Prescription drugs can carry a wide range of side effects, some of which lead to serious or life-threatening consequences in thousands of individuals every year. Many of these complications are otherwise avoidable and could be attributed to medical malpractice or medical negligence. If you’ve suffered harm or injury because of a prescription drug, you may be wondering whether you can sue your doctor, or who...

read more

When we are prescribed a pharmaceutical drug by our doctors, we trust that the drugs we are taking will help treat our medical condition, not that they will cause additional health complications, some of which may be extremely serious or even life threatening. Some drug injuries occur because of inherent problems with a dangerous or inadequately tested drug and many times, these dangerous side effects...

read more

The United States is in the midst of a massive opioid epidemic which continues to grow in size and scope every year. Approximately 55,000 people in the United States die from a drug overdose each year, making it the leading cause of death in those under the age of 50. Of those deaths, approximately 60 percent are caused by opioids. Over the past 17 years,...

read more

Hair loss is one of the most well-known side-effects of chemotherapy or cancer treatment, so much so that a bald head has become a near universal symbol of cancer patients across our society and in the media. The hair loss from chemotherapy is supposed to be temporary, however, many of those who were taking Taxotere have found their hair loss to be permanent. While many...

read more

Mesothelioma is a rare and extremely aggressive form of cancer that develops in the lining of the lungs, abdomen, or heart, and is caused almost exclusively by exposure to asbestos. Unfortunately, mesothelioma has no known cure at this time and it also has a very poor prognosis for survival. According to a 2017 report by the Centers for Disease Control (CDC), approximately 2,500 people are...

read more

The Pradaxa lawsuit has inspired the lawsuits against Xarelto’s manufacturer for similar injuries sustained. Both drugs were designed, developed, and marketed as better alternatives to Coumedin. The main benefit was eliminating the requirement of constant blood tests which was both time-consuming and annoying for patients. Since both drugs were created, internal bleeding and even death have occurred among users. Lawsuits by both users of the...

read more

Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemorrhage, or severe trauma following an automobile accident, there is a marginally improved chance for the patient to survive invasive procedures. The specific study mentioned that the timing of the treatment is crucial, such...

read more

Additional lawsuits filed this year in Ohio and Pennsylvania allege that the blood thinner drug Xarelto is causing serious injuries and death to patients nationwide. Xarelto has been proven to cause complications, such as: excessive bleeding, red or black stools, frequent nosebleeds, pink or brown urine, unexplained bruises, bruises that increase in size, coughing up blood or blood clots, vomiting blood or vomit that resembles...

read more

Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March 13, 2017. Mississippi’s Xarelto trials will be held on April 24, 2017. In...

read more

Many Xarelto lawsuits that have been filed against Johnson & Johnson and Bayer Corporation allege that the pharmaceutical companies failed to disclose the reality of the blood thinner’s risks and dangers. Xarelto has been prescribed as a blood thinner to treat many conditions, from nonvalvular atrial fibrillation, deep vein thrombosis, to pulmonary embolism. The favorable studies that center on the drug’s positive outcomes are also...

read more

Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant threat to Pradaxa patients. The Committee for Medicinial Products for Human Use (CHMP) recommended...

read more

Last month, Huffington Post published a 58,000 word series on Johnson & Johnson’s illegal marketing of the dangerous drug Risperdal. Risperdal is proven to cause young boys to grow large breasts. The series exposes unethical and illegal behavior from Johnson and Johnson since Risperdal’s release in 1994. We can all take steps to ensure that Johnson & Johnson is accountable for manufacturing and selling dangerous drugs....

read more

Jasnssen Pharmaceuticals, Inc. published a recent study on the safety of Xarelto, where the drug manufacturer attempted to minimize the injuries and uncontrolled bleeding that Xarelto patients are suffering globally. Over 45,000 patients participated in the study. Janssen and the marketing firm that assisted with the study concluded that almost 3 out of 100 Xarelto patients experienced major bleeding. Our reports show that the issues with bleeding...

read more

The Washington Post published an article recently reporting concerns that the FDA did not adequately review the safety and risks of the Pradaxa blood thinner. Reports of Pradaxa injuries are coming in daily to our office, including an Indiana man who has been taking Pradaxa since 2013, and now has blood in his urine, a Vermont woman who took Pradaxa since 2011 and now has internal bleeding,...

read more

Pradaxa is a prescription blood thinner medicine that lowers the chance of blood clots forming in your body. It is commonly prescribed to reduce the risk of stroke and blood clots in patients with Atrial Fibrillation that is not caused by a heart valve problem. Pradaxa is also used to treat blood clots in the veins of the legs (Deep vein thrombosis, or DVT) or lungs (Pulmonary...

read more

Huffington Post has published “The Miracle Industry Series,” where the news outlet reveals that Johnson & Johnson spent 20 years marketing the drug Risperdal to children and the elderly. Once again, pharmaceutical profits won out over safety and the truth about the side effects. Huffington Post reveals that Johnson & Johnson’s “strategies, tactics, and mindset should make us wonder about the prescription drugs that are...

read more

Although the U.S. FDA approved Xarelto in 2011, many patients have experienced liver injuries and uncontrolled bleeding, resulting in severe damage and even death in some cases. In August, 2015, Canadian regulators announced an official investigation into numerous reports of liver injuries due to Xarelto use. The report states, “This issue was identified after two publications in the scientific literature described liver injury linked to the use...

read more

 Dr. Joseph Murray of the May Clinic has linked the condition sprue-like enteropathy to Benicar, a medication for high blood pressure. The list of symptoms and side effects related to Benicar use is growing. The small intestine can become damaged to the point where it cannot absorb nutrients effectively after Benicar use. Next, chronic diarrhea sets in, and kidney damage. Even more troubling, Benicar use can lead...

read more

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep vein thrombosis (DVT) and pulmonary embolism. Unfortunately, hundreds of patients...

read more

MISSION HILLS, CA – Sean David Pulskamp died tragically after taking Xarelto for three months. The cause of death was listed as cardiopulmonary arrest, pulmonary embolism, deep vein thrombosis, and pulmonary hypertension. Mr. Pulskamp was only 19 years old. Growing concerns over deaths and complications from blood thinners like Xarelto are forcing leading cardiologists to reconsider prescribing them. These risks and trends should not be...

read more

A new generation of anticoagulants, namely Xarelto and Pradaxa, have been at the center of much controversy in recent times. The manufacturers of these drugs have seen a significant increase in sales of their drugs, thanks in part to how convenient they are compared to more traditional blood thinners. However, the significant sales of these drugs can also be linked to Gregory Lip, a British heart...

read more

Since December 2014, all federal Xarelto lawsuits have been consolidated in the Eastern District of Louisiana. Any federal lawsuits filed against Janssen Pharmaceuticals and Bayer AG, the manufacturers of Xarelto (rivaroxaban), would have been transferred to the Louisiana court for pre-trial proceedings. By moving all cases into one court, federal judges expect to increase efficiency by all parties involved. Plaintiffs who have brought forth lawsuits...

read more

In the recent June 2015 issue of JAMA Ophthalmology, researchers studied some of Xarelto’s disturbing side effects, further calling into question the safety of the drug. These scientists studied the link between Xarelto usage and the possibility of an increase in stomach bleeds and eye hemorrhaging. Drs. Judy H. Hun and John C. Hwang found that patients in their 70s and 80s who had taken Xarelto after...

read more

A new experimental drug has been proven to reverse the effects of the drug Pradaxa (dabigatran). The drug, called idarucizumab, is said to work within minutes of being given to patients. Pradaxa is a newer anticoagulant that has been marketed as an easier alternative to traditional blood thinners. Unfortunately, it was not created alongside an antidote that could undo the potentially deadly side effects that...

read more

A recent study has revealed that mothers who take Xarelto can pass down the drug to their unborn child. When ingested during pregnancy, the anticoagulant transfers back and forth across the placenta between a mother and her fetus. The study was done by a research team at The Motherisk Program at the Hospital for Sick Children in Toronto and published most recently in the American...

read more

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has recently seen an increase in sales even as the drug continues to cause problems for a significant number of patients. In the first quarter of 2015, both Xarelto sales and J& J pharmaceutical division sales increased by 3% to $7.7 billion. Bayer has increased its forecast for Xarelto’s 2015 sales growth to...

read more

Xarelto, a relatively new prescription blood thinner, was first approved by the FDA in 2011 for patients who were at risk of developing blood clots as a result of knee or hip replacement surgeries. The marketers of the anticoagulant, Janssen Pharmaceuticals, aggressively marketed the drug as a “one-size-fits-all” drug. Given that, doctors readily prescribed the drug because it didn’t require them to monitor their patients...

read more

Foreign regulators in Australia are questioning whether additional blood monitoring on new anticoagulants would make the drugs safer. These drugs include Pradaxa, Eliquis and more specifically, Xarelto. The Australian Therapeutic Goods Administration recently announced this month that it had completed a review of new oral anticoagulants like Xarelto and have concluded that regular blood monitoring would not improve the drugs. The group came to this...

read more

According to a new study published recently by the Johns Hopkins Bloomberg School of Public Health and George Washington University, Xarelto, along with Pradaxa, may pose an increased risk of gastrointestinal bleeding in patients. Patients who instead choose to take warfarin, an older anticoagulant, appear to have a decreased change of experiencing these side effects. The study followed 46,000 patients that were given either Pardaxa,...

read more

This year has seen a significant increase in the number of law suits being brought against the manufacturers of Xarelto, Johnson & Johnson and Bayer Corp.. Individuals and their families allege that they have faced harmful negative side effects after taking the drug and that Johnson & Johnson and Bayer knew this, but still aggressively marketed their blockbuster drug to consumers. Dozens so far have...

read more

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage, Bayer Healthcare claimed, was that patients would not have to...

read more

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)